Skip to content

Publications

Academic Myeloma Consortium (AMyC)

Explore AMyC

AMyC Home
Institutions & Investigators
About
News & Events
Facts

Explore Oncology Consortia

GI Cancer (AGICC)
Breast Cancer (ABRCC)
Thoracic Oncology (ATOMIC)
GU Cancer (AURIC)
Safety and Efficacy of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
This study sought to evaluate the safety and efficacy of carfilzomib in patients with AL.
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
This is the first clinical trial to investigate CPD in multiple myeloma. Results suggest that the regimen is a well-tolerated and highly active combination for patients with relapsed/refractory multiple myeloma.